Risk-reducing Strategies, Including Fimbriectomy, in Women With a Germline Mutation Predisposing to Ovarian or Pelvic Cancer

Clinical trial NCT06726330 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06726330
Sponsor: Centre Oscar Lambret
Status: NOT_YET_RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Tubo-ovarian Carcinoma High-grade Serous Carcinoma Primary Peritoneal Carcinoma Stage III Primary Peritoneal Carcinoma Stage IV Primary Peritoneal Carcinoma

Start date: 2027-03-01
Primary completion: 2071-03-01
Enrollment: 1100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.